Zenopharm
Dr. Wang has published over 100 peer-reviewed scientific papers, filed 10 patents, and obtained federal and state research funding exceeding $40 million as PI.
This person is not in any offices
Zenopharm
Zenopharm is a startup pharmaceutical company founded in 2012 to commercialize innovative oncology therapeutics based on its patented platform technology. Zenopharm is developing transformational therapeutic solutions for the treatment of advanced or metastatic breast cancer.